The systemic score may identify life-threatening evolution in Still's disease: data from the GIRRCS AOSD-study group and the AIDA Network Still's Disease Registry.


Journal

Arthritis & rheumatology (Hoboken, N.J.)
ISSN: 2326-5205
Titre abrégé: Arthritis Rheumatol
Pays: United States
ID NLM: 101623795

Informations de publication

Date de publication:
18 Mar 2024
Historique:
revised: 21 02 2024
received: 01 11 2023
accepted: 12 03 2024
medline: 19 3 2024
pubmed: 19 3 2024
entrez: 19 3 2024
Statut: aheadofprint

Résumé

To evaluate the clinical usefulness of the systemic score in the prediction of life-threatening evolution in Still's disease. To assess the clinical relevance of each component of the systemic score in predicting life-threatening evolution and to derive patient subsets accordingly. A multicenter, observational, prospective study was designed including patients included in the GIRRCS (Gruppo Italiano Di Ricerca in Reumatologia Clinica e Sperimentale) AOSD-study group and AIDA (AutoInflammatory Disease Alliance) Network Still's Disease Registry. Patients were assessed if variables to derive the systemic score were available. The life-threatening evolution was defined as mortality, whichever the clinical course, and/or macrophage activation syndrome (MAS), a secondary hemophagocytic lymphohistiocytosis associated with a poor prognosis. Totally 597 patients with Still's disease were assessed (age 36.6±17.3 years; male 44.4%). The systemic score, assessed as continuous variable, significantly predicted the life-threatening evolution (OR: 1.24, 95%CI:1.07-1.42; p=0.004). A systemic score ≥7 also significantly predicted the likelihood of a patient experiencing life-threatening evolution (OR: 3.36, 95%CI:1.81-6.25; p<0.001). Assessing the clinical relevance of each component of the systemic score, liver involvement (OR: 1.68, 95%CI:1.48-2.67; p=0.031) and lung disease (OR: 2.12, 95%CI:1.14-4.49; p=0.042) both significantly predicted life-threatening evolution. The clinical characteristics of patients with liver involvement and lung disease were derived, highlighting their relevance in multiorgan disease manifestations. The clinical utility of the systemic score was shown in identifying Still's disease at higher risk of life-threatening evolution in a large cohort. Furthermore, the clinical relevance of liver involvement and lung disease was highlighted.

Identifiants

pubmed: 38499989
doi: 10.1002/art.42845
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

This article is protected by copyright. All rights reserved.

Auteurs

Piero Ruscitti (P)

Rheumatology Unit, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.

Francesco Masedu (F)

Rheumatology Unit, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.

Antonio Vitale (A)

Department of Medical Sciences, Surgery and Neurosciences, Research Center of Systemic Autoinflammatory Diseases and Behçet's Disease Clinic, University of Siena, Siena, Italy.
Azienda Ospedaliero-Universitaria Senese [European Reference Network (ERN) for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (RITA) Center] Siena, Italy.

Valeria Caggiano (V)

Department of Medical Sciences, Surgery and Neurosciences, Research Center of Systemic Autoinflammatory Diseases and Behçet's Disease Clinic, University of Siena, Siena, Italy.
Azienda Ospedaliero-Universitaria Senese [European Reference Network (ERN) for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (RITA) Center] Siena, Italy.

Ilenia Di Cola (I)

Rheumatology Unit, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.

Paola Cipriani (P)

Rheumatology Unit, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.

Marco Valenti (M)

Rheumatology Unit, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.

Henrique A Mayrink Giardini (HAM)

Rheumatology Division, Faculdade de Medicina, Hospital das Clínicas, Universidade de São Paulo, São Paulo, Brazil.

Isabele Parente de Brito Antonelli (I)

Rheumatology Division, Faculdade de Medicina, Hospital das Clínicas, Universidade de São Paulo, São Paulo, Brazil.

Marilia Ambiel Dagostin (MA)

Rheumatology Division, Faculdade de Medicina, Hospital das Clínicas, Universidade de São Paulo, São Paulo, Brazil.

Giuseppe Lopalco (G)

Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J) Policlinic Hospital, University of Bari, Bari, Italy.

Florenzo Iannone (F)

Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J) Policlinic Hospital, University of Bari, Bari, Italy.

Morrone Maria (M)

Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J) Policlinic Hospital, University of Bari, Bari, Italy.

Ibrahim A Almaghlouth (IA)

Rheumatology Unit, Department of Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
College of Medicine Research Center, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

Kazi Nur Asfina (KN)

College of Medicine Research Center, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

Hebatallah Hamed Ali (HH)

College of Medicine Research Center, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

Francesco Ciccia (F)

Department of Precision Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.

Daniela Iacono (D)

Department of Precision Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.

Ilenia Pantano (I)

Department of Precision Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.

Daniele Mauro (D)

Department of Precision Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.

Petros P Sfikakis (PP)

Joint Academic Rheumatology Program, Medical School, National and Kapodistrian University of Athens, Athens, Greece.

Maria Tektonidou (M)

Joint Academic Rheumatology Program, Medical School, National and Kapodistrian University of Athens, Athens, Greece.

Katerina Laskari (K)

Joint Academic Rheumatology Program, Medical School, National and Kapodistrian University of Athens, Athens, Greece.

Onorina Berardicurti (O)

Clinical and research section of Rheumatology and Clinical Immunology, Fondazione Policlinico Campus Bio-Medico, Via Álvaro del Portillo 200, 00128, Rome, Italy.
Rheumatology, Immunology and Clinical Medicine Unit, Department of Medicine, University of Rome "Campus Biomedico" School of Medicine, Rome, Italy.

Lorenzo Dagna (L)

Division of Immunology, Transplants and Infectious Diseases, Università Vita-Salute San Raffaele, Milan, Italy.
Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS Ospedale San Raffaele, Milan, Italy.

Alessandro Tomelleri (A)

Division of Immunology, Transplants and Infectious Diseases, Università Vita-Salute San Raffaele, Milan, Italy.
Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS Ospedale San Raffaele, Milan, Italy.

Abdurrahman Tufan (A)

Gazi University Hospital, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey.

Rıza Can Kardas (RC)

Gazi University Hospital, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey.

Andrea Hinojosa-Azaola (A)

Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.

Eduardo Martín-Nares (E)

Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.

Perla Ayumi Kawakami-Campos (PA)

Department of Ophthalmology Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Mexico City, Mexico.

Gaafar Ragab (G)

Internal Medicine Department, Rheumatology and Clinical Immunology Unit, Faculty of Medicine, Cairo University, Egypt.
Faculty of Medicine, Newgiza University (NGU), Egypt.

Mohamed Tharwat Hegazy (M)

Internal Medicine Department, Rheumatology and Clinical Immunology Unit, Faculty of Medicine, Cairo University, Egypt.
Faculty of Medicine, Newgiza University (NGU), Egypt.

Haner Direskeneli (H)

Department of Internal Medicine, Division of Rheumatology, Marmara University, Faculty of Medicine, Istanbul, Turkey.

Fatma Alibaz-Oner (F)

Department of Internal Medicine, Division of Rheumatology, Marmara University, Faculty of Medicine, Istanbul, Turkey.

Lampros Fotis (L)

Department of Pediatrics, Attikon General Hospital, National and Kapodistrian University of Athens, Greece.

Paolo Sfriso (P)

Rheumatology Unit, Department of Medicine, University of Padua, Padua, Italy.

Marcello Govoni (M)

Rheumatology Unit, Department of Medical Sciences, Azienda Ospedaliero-Universitaria S. Anna-Ferrara, University of Ferrara, Ferrara, Italy.

Francesco La Torre (F)

Department of Pediatrics, Pediatric Rheumatology Center, Giovanni XXIII Pediatric Hospital, University of Bari, Bari, Italy.

Maria Cristina Maggio (MC)

University Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE) "G. D'Alessandro", University of Palermo, Palermo, Italy.

Carlomaurizio Montecucco (C)

Department of Internal Medicine and Therapeutics, University of Pavia, Italy.
Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Ludovico De Stefano (L)

Department of Internal Medicine and Therapeutics, University of Pavia, Italy.
Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Serena Bugatti (S)

Department of Internal Medicine and Therapeutics, University of Pavia, Italy.
Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Silvia Rossi (S)

Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Joanna Makowska (J)

Department of Rheumatology, Medical University of Lodz, Zeromskiego 113, 90-549 Lodz, Poland.

Emanuela Del Giudice (E)

Pediatric and Neonatology Unit, Department of Maternal Infantile and Urological Sciences, Sapienza University of Rome, Latina, Italy.

Giacomo Emmi (G)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Centre for Inflammatory Diseases, Department of Medicine, Monash Medical Centre, Monash University, Clayton, VIC, Australia.

Elena Bartoloni (E)

Rheumatology Unit, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.

José Hernández-Rodríguez (J)

Department of Autoimmune Diseases, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Hospital Clínic of Barcelona [European Reference Network (ERN) for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (RITA) Center], University of Barcelona, Barcelona, Spain.

Giovanni Conti (G)

Pediatric Nephrology and Rheumatology Unit, Azienda Ospedaliera Universitaria (AOU), "G. Martino" Messina, Italy.

Alma Nunzia Olivieri (AN)

Department of Woman, Child and of General and Specialized Surgery, University of Campania "Luigi Vanvitelli", Naples, Italy.

Alberto Lo Gullo (A)

UOSD Reumatologia, ARNAS Garibaldi, Catania, Italy.

Gabriele Simonini (G)

NEUROFARBA Department, Rheumatology Unit, Meyer Children's Hospital IRCCS, University of Florence, Florence, Italy.

Ombretta Viapiana (O)

Rheumatology Unit, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Italy.

Ewa Wiesik-Szewczyk (E)

Department of Internal Medicine, Pneumonology, Allergology and Clinical Immunology, Central Clinical Hospital of the Ministry of National Defense, Military Institute of Medicine, National Research Institute, Warsaw, Poland.

Sukran Erten (S)

Department of Rheumatology, Faculty of Medicine Ankara City Hospital, Ankara Yıldırım Beyazıt University, Ankara, Turkey.

Francesco Carubbi (F)

Department of Life, Health & Environmental Sciences and Internal Medicine and Nephrology Unit, Department of Medicine, University of L'Aquila and ASL Avezzano-Sulmona-L'Aquila, San Salvatore Hospital, L'Aquila, Italy.

Amato De Paulis (A)

Department of Translational Medical Sciences, Section of Clinical Immunology, University of Naples Federico II, Naples, Italy; 39 - Center for Basic and Clinical Immunology Research (CISI), WAO Center of Excellence, University of Naples Federico II, Naples, Italy.

Armin Maier (A)

Rheumatology Unit, Department of Medicine, Central Hospital of Bolzano, Bolzano, Italy.

Samar Tharwat (S)

Rheumatology and Immunology Unit, Internal Medicine Department, Mansoura University, Mansoura, Egypt.
Department of Internal Medicine, Faculty of Medicine, Horus University, New Damietta, Egypt.

Stefania Costi (S)

Department of Clinical Sciences and Community Health, Research Center for Adult and Pediatric Rheumatic Diseases, University of Milan, Milan, Italy.

Annamaria Iagnocco (A)

Academic Rheumatology Centre, Ospedale Mauriziano - Dipartimento Scienze Cliniche e Biologiche, Università degli Studi di Torino, Turin, Italy.

Gian Domenico Sebastiani (GD)

UOC di Reumatologia, Azienda Ospedaliera San Camillo Forlanini, Roma, Italy.

Antonio Gidaro (A)

Department of Biomedical and Clinical Sciences Luigi Sacco, Luigi Sacco Hospital, University of Milan, Milan, Italy.

Antonio Luca Brucato (AL)

Pediatric Unit, Fatebenefratelli Hospital, Milan, Italy.

Anastasios Karamanakos (A)

Joint Academic Rheumatology Program, First Department of Propaedeutic and Internal Medicine, National and Kapodistrian University of Athens, Mikras Asias Street 75 Goudi, Athens, 11527, Greece.

Nurullah Akkoç (N)

Division of Rheumatology, Department of Internal Medicine, School of Medicine, Manisa Celal Bayar University, Manisa, Turkey.

Francesco Caso (F)

Rheumatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.

Luisa Costa (L)

Rheumatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.

Marcella Prete (M)

Rheumatic and Systemic Autoimmune Diseases Unit, Department of Interdisciplinary Medicine (DIM), University of Bari Medical School, Italy.

Federico Perosa (F)

Rheumatic and Systemic Autoimmune Diseases Unit, Department of Interdisciplinary Medicine (DIM), University of Bari Medical School, Italy.

Fabiola Atzeni (F)

Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Messina, Italy.

Giuliana Guggino (G)

Rheumatology Section, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University Hospital P. Giaccone, Palermo, Italy.

Claudia Fabiani (C)

Department of Medical Sciences, Surgery and Neurosciences, Research Center of Systemic Autoinflammatory Diseases and Behçet's Disease Clinic, University of Siena, Siena, Italy.
Azienda Ospedaliero-Universitaria Senese [European Reference Network (ERN) for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (RITA) Center] Siena, Italy.

Bruno Frediani (B)

Department of Medical Sciences, Surgery and Neurosciences, Research Center of Systemic Autoinflammatory Diseases and Behçet's Disease Clinic, University of Siena, Siena, Italy.
Azienda Ospedaliero-Universitaria Senese [European Reference Network (ERN) for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (RITA) Center] Siena, Italy.

Roberto Giacomelli (R)

Clinical and research section of Rheumatology and Clinical Immunology, Fondazione Policlinico Campus Bio-Medico, Via Álvaro del Portillo 200, 00128, Rome, Italy.
Rheumatology, Immunology and Clinical Medicine Unit, Department of Medicine, University of Rome "Campus Biomedico" School of Medicine, Rome, Italy.

Luca Cantarini (L)

Department of Medical Sciences, Surgery and Neurosciences, Research Center of Systemic Autoinflammatory Diseases and Behçet's Disease Clinic, University of Siena, Siena, Italy.
Azienda Ospedaliero-Universitaria Senese [European Reference Network (ERN) for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (RITA) Center] Siena, Italy.

Classifications MeSH